Ig Acquisition (IGAC) Annual Balance Sheets

Annual · GAAP · USD millions
Access IGAC quarterly Balance Sheets →
Looking at balance sheet data from Ig Acquisition through provides insight into Dec 31 2021's solvency and capital structure over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020)
Assets
Cash & cash equivalent0.09
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.04
Total Current Assets0.13
Other Assets, Noncurrent300.00
Total Assets300.15
Liabilities
Loans Payable, Current NO0.20
Taxes Payable, Current, Total1.55
Total Current Liabilities12.25
Total Long-term Debt0.00
Other liabilities, Noncurrent18.40
DeferredUnderwritingFeePayable10.50
Total Liabilities30.65
Stockholders' Equity
Common Stock Value Subject To Possible Redemption300.00
Common Stock Value One0.00
Common Stock Value-
Retained Earnings / Accumulated Deficit-30.50
Other Equity-300.00
Common Stockholder's Equity-30.49
Total Stockholder's Equity-30.49
Liabilities & Stockholder's Equity300.15
4 historic quarters locked

Sign in to unlock the full Ig Acquisition balance sheet history.

About Ig Acquisition Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-22-069784

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.